You are here

  • Home
  • Archive
  • Volume 106, Issue 8
  • Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)

Article metrics

Article menu

Download PDFPDF

Clinical science
Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)

 

Online download statistics by month:

Online download statistics by month: March 2021 to August 2024

AbstractFullPdf
Mar 2021130112911101
Apr 2021133613331160
May 202118918858
Jun 202112912822
Jul 202115014925
Aug 202113613322
Sep 202112812435
Oct 202112912659
Nov 202114814579
Dec 202115315040
Jan 202214715838
Feb 202215515551
Mar 202217617641
Apr 202220620452
May 202218418045
Jun 202222822634
Jul 202242642759
Aug 202236435949
Sep 2022908828
Oct 2022727130
Nov 2022545533
Dec 2022697046
Jan 2023444467
Feb 2023524818
Mar 2023565624
Apr 2023363619
May 2023262619
Jun 2023484724
Jul 2023494930
Aug 2023393714
Sep 2023605720
Oct 202315415120
Nov 202326426517
Dec 20231019924
Jan 2024343424
Feb 2024242415
Mar 2024363576
Apr 2024383725
May 2024414016
Jun 2024353427
Jul 2024323021
Aug 2024403322
Total717971183629